20 May 2013
Keywords: GW Pharmaceutical, cannabinoid medicine, Sativex, Great Point Partners
Article | 06 August 2009
GW Pharmaceutical, the UK developer and manufacturer of a range of new cannabinoid medicines, including Sativex, has signed an agreement ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
6 August 2009
17 May 2013
© 2013 thepharmaletter.com